RALEIGH, N.C., July 19, 2016 /PRNewswire/ -- Myocardial Solutions, Inc. ("MSI") announced the launch of its website, http://myocardialsolutions.com, to educate patients and physicians about its proprietary SENC technology. SENC may transform the cardiac magnetic resonance testing ("CMR") market by significantly improving testing speed and ease, while maintaining strong accuracy through quantitative analysis. The Company's first commercial products are targeting the cardiac stress market, with over 8 million annual tests in the US market alone.
The Company's goal is to provide a CMR stress test that can be performed in under 15 minutes with just 3-4 minutes of patient time within the magnet scanner. The Company is presently working with Philips' technology in four sites to confirm previous results from a 320 patient trial performed in Heidelberg, Germany. Results from Heidelberg demonstrated that SENC provides both clinical and financial advantages over existing CMR modalities.
"The SENC technology has the potential to create a new gold standard for stress testing. The Company is in the midst of commercializing technology that has long been the gold standard for strain testing in the research market. With over 250 peer reviewed articles, this technology is positioned to make significant market impact," said Dr. Nael Osman, Chief Technology Officer of MSI.
The company is not presently FDA cleared, and has not commercialized its products.
About Myocardial Solutions, Inc.:
The Company was founded in January, 2016 to commercialize software applications for fast processing of CMR imaging with objective quantified results. The goal is to create wide spread adoption of CMR diagnostics.